At first glance, one might ask why? After all, who - other than the pilot - would fly with Thomas Cook sober?
However, there's a world of difference between being not entirely sober and Ms Heyes's level of intoxication, which according to the judge at Greater Manchester Magistrates Court, made her 'every passenger's worst nightmare', and earned her a sentence of 80 hours community service, a victim surcharge of £80 and £250 in costs.
At the start of her disciplinary hearing, Ms Heyes admitted the facts of her 2020 conviction, but denied that the conviction rendered her unfit to practise as a veterinary nurse.
The Committee then considered whether Ms Heyes's conduct amounted to serious professional misconduct.
The Disciplinary Guidance states: “A conviction may be related to professional or personal behaviour and whether it renders a respondent unfit to practise is a matter of judgment for the Disciplinary Committee.
"Behaviour unconnected with the practice of veterinary surgery can cause concerns about the protection of animals or the wider public interest.”
The Committee concluded that the conviction and underlying behaviour was sufficiently serious that it required a finding that Ms Heyes was unfit to practise veterinary nursing on public interest grounds and that it also breached Code 6.5 of the Code of Professional Conduct for Veterinary Nurses which states: ‘Veterinary nurses must not engage in any activity or behaviour that would be likely to bring the profession into disrepute or undermine public confidence in the profession’.
The Committee then considered the most appropriate sanction for Ms Heyes, taking into account the relevant aggravating and mitigating factors.
Aggravating factors included the risk Ms Heyes caused to passengers, including children and that she had behaved recklessly, falling far below the standard to be expected of a member of the veterinary nursing profession.
In mitigation, the Committee considered this was a single and isolated incident, Ms Heyes had no previous disciplinary findings against her and following her conviction she had shown developing insight.
It also noted that she had continued to practise as a competent and dedicated veterinary nurse.
Cerys Jones, chairing the Committee and speaking on its behalf, said: “The Committee decided to reprimand Ms Heyes because of its finding that the charge amounted to disgraceful conduct and rendered Ms Heyes unfit to practise.
"Such a sanction was necessary in the Committee’s view because the conviction brought the profession into disrepute.
"Whilst the charge was not so serious as to require suspension or removal from the register, the Committee decided it is necessary to issue a formal warning to Ms Heyes as to her future conduct.
“Taking into account the overall circumstances of the case including the positive references and the fact that a number of mitigating factors set out in the Disciplinary Committee Sanctions Guidance were present in this case, the Committee was satisfied that this sanction would meet the public interest and protect the reputation of the profession and uphold standards within the profession; thereby maintaining public confidence in the College as the regulator for veterinary nurses.”
The full details of the hearing and the Committee’s decision can be found at www.rcvs.org.uk/disciplinary
Organisers of The London Vet Show 2009 report that the event was a great sucess, greeted with 'considerable delight' by delegates and exhibitors alike.
The event, which featured clinical and commercial lectures as well as a major exhibition, ran on 6th and 7th November at London's Olympia Conference Centre. 2410 veterinary professionals attended, and most were there for both days.
VetSurgeon.org attended the event, asking commercial exhibitors: "What's New?" Those of you that didn't make it to the show can click here to watch a video of their answers.
Overall feedback from vets about the quality of the CPD programme was overwhelmingly positive. Delegate feedback forms rated the quality of speakers in the programme as 4.39 out of 5, and rated the event as 4.68 out of 5 in terms of value for money.
Rachel Bolus of Riverside Veterinary Practice said: "All the lectures were to a really good standard - a lot of CPD for a very cheap price."
Bridget O'Farrell of Dick Vet Small Animal Practice agreed: "Very cheap for two days of CPD and the quality of the speakers has been very good. I went to five lectures yesterday and planning on six today. It's been a very worthwhile exercise and I would certainly recommend this to my peers".
Event organiser Phil Nelson said: "We have witnessed an amazing two days, surpassing all delegate estimates and it's gone down really well. The 2010 exhibition is already 40% bigger than this year almost 12 months out and looks set to sell out. We are carefully listening to the delegates and exhibitors comments, and have already a number of plans to develop and build the event going forward. But as a starting point we could never have dreamt for the launch event to be so well received."
For 2010 the London Vet Show is moving to the bigger Olympia National Hall having out grown the Conference Centre. It will run on October 22nd and 23rd. It is committed to retaining the same approach to offering affordable and World Class CPD qualifying clinical and commercial content for all the UKs vets. Having very quickly established itself as a major part of the veterinary calendar the organisers expect to announce their 2010 programme in the early part of 2010.
The RCVS Registered Veterinary Nurse Disciplinary Committee has suspended a Northants-based registered veterinary nurse who admitted to acting dishonestly with her employer, a client and a pet database company by taking home a patient that was supposed to have been euthanised.
During the two-day hearing, the Committee heard how Sally-Ann Roberts, formerly of the Best Friends Veterinary Group in Thrapston, had deliberately gone against the wishes of the owners of a 14-year-old Maine Coon cat called Jason that he be euthanised, rather than treated further, and instead had taken the cat home with her for "intensive nursing". Jason had subsequently escaped from Ms Robert's residence, leading her to fabricate a story, first to the pet database company, and then to Jason's owners and her employer, that he had escaped from the practice, before being returned by a member of the public two days later and then euthanised as originally requested.
Ms Roberts acted with her veterinary surgeon colleague Przemyslaw Bogdanowicz, who chose not to euthanise Jason and who, for his part, received a three-month suspension from the RCVS Disciplinary Committee in December 2012. She repeated the false account on a number of occasions, both orally and in written statements, and also forged the signature of Jason's owner on official documentation in order to substantiate her story.
Only when Ms Roberts was interviewed for a second time by her then employer's area manager, did she finally admit to what had actually happened. Shortly afterwards, Ms Roberts was suspended from the practice and, following an internal disciplinary hearing a few days later, was dismissed by them for gross misconduct, along with Mr Bogdanowicz. There was no evidence available as to what ultimately happened to Jason.
Explaining her actions to the Committee, Ms Roberts said she was upset that Jason's owners wanted him to be euthanised and felt that he could recover if given some love and attention. She had asked Mr Bogdanowicz to discuss this possibility with Jason's owners, but he had refused, agreeing instead that she could continue Jason's treatment at her home. After Jason escaped, Ms Roberts said she was "devastated" and had "panicked", inventing the story of Jason's escape to cover her actions, which she now acknowledged were "wrong" and "stupid", and which she "bitterly regretted". Ms Roberts expressed sorrow and remorse for her behaviour, which she said would never occur again, and stated that being a veterinary nurse was everything to her.
In view of the admitted facts, the Committee judged that Ms Robert's dishonesty and breach of client trust, as well the distinct risk of injury to which she exposed Jason, amounted to serious professional misconduct. In deciding on an appropriate sanction, the Committee balanced a number of aggravating factors (in particular, the forged signature) against Ms Roberts' "strong mitigation", which included her admitting the entirety of the charges against her, her medical and personal problems at the time, the insight she had shown into the effects of her actions on Jason's owners and her previous unblemished career.
Professor Peter Lees, chairing and speak on behalf of the Committee, said: "The Committee has concluded that the Respondent has shown insight into the seriousness of her misconduct and that there is no significant risk of repeat behaviour. In light of the Respondent's admission, her insight, her remorse and the high regard in which she is held by her professional colleagues, it is the Committee's view that the sanction of two months' suspension is appropriate and proportionate."
The Committee's full decisions on facts and sanction are available at www.rcvs.org.uk/disciplinary.
Addison’s disease is caused by a reduction in corticosteroid secretion from the adrenal glands. Symptoms can include lack of appetite, tremors or vomiting, diarrhoea, lethargy, low heart rate, muscle weakness, low body temperature and collapse. If left untreated, Addison’s disease can present as an acute, life-threatening emergency.
Zycortal is the only European licensed treatment for the disease. It is a prolonged-release suspension used as replacement therapy for mineralocorticoid. Dechra says it has proved highly effective in clinical trials with more than 80% of dogs responding positively to treatment1.
The golden rules are available at: www.dechra.co.uk/goldenrules.
Dechra has also produced a series of six video presentations to help veterinary surgeons in their diagnosis and treatment and created a dedicated owner website - www.myaddisonsdog.co.uk - to help owners understand the condition and monitor their pet's progress.
Dechra Brand Manager Craig Sankey said: "Addison’s can be a hidden disease but Zycortal presents a very visible answer. With the wealth of expertise from the endocrinologists, the Five Golden Rules should be an important reference tool for vets.
"We hope that the series of resources we have produced, used in partnership with Zycortal, will make the diagnosis, treatment and management of dogs with Addison’s an easier journey for both vets and owner."
Reference
The marketing pack includes a poster, leaflet and a counter top display which highlight the stress factors facing pets and provide pet owners with an overview of how Feliway and Adaptil help pets cope with challenging situations.
Ceva will also be running a competition for pet owners to win £150 of John Lewis vouchers in a prize draw. To enter, they need to email cevauk@ceva.com with the subject 'Stress Free Christmas' and their name and contact number. The competition closes on 24 December 2017 and the winner will be contacted by telephone in January 2018.
Claire Russell, brand manager at Ceva Animal Health, said: "Big family gatherings, noisy toys and being home alone more often are just some of the stressful situations that pets can find themselves in during the festive period. Our new marketing pack will help highlight these stress factors amongst pet owners and raise awareness of how Feliway and Adaptil can help support their pets."
To request a Christmas marketing pack, contact your Ceva Animal Health account manager, email cevauk@ceva.com or contact customer services on 01494 781510.
Pet owners visiting the University of Edinburgh's vet school will be able to relax in peaceful outdoor surroundings, thanks to a project supported by the BBC's Beechgrove Garden.
The primetime gardening show's team, together with volunteers and friends of the Royal (Dick) School of Veterinary Studies, have transformed a two-and-a-half-acre plot in the vet school grounds into a community garden.
The sloping landscaped garden features a network of paths surrounding flower beds, trees and bushes. Sculpted stone seats give visitors a place to relax. Clients of the Dick Vet are being invited to support the school by sponsoring a brick along a path that winds through the garden, or by sponsoring trees, plants or benches.
Lesley Watson, a Beechgrove Garden presenter, said: "We have had a lot of help from the community in creating this garden, in what was a huge site. The first part of the garden, next to the School buildings, is quite formal, but as it extends towards the hills beyond, it becomes a more relaxed space and starts to take on aspects of the wider landscape."
Professor Elaine Watson, Head of the Royal (Dick) School of Veterinary Studies, said: "This wonderful garden is a fantastic place for our pet owners to visit and also a beautiful green retreat for our staff and students to enjoy."
Inez Priestly, a dog owner whose pets have been treated at the Dick Vet, laid the first brick in the garden's path of memories, in honour of her late Cavalier King Spaniel, Treacle. Mrs Priestly said: "The treatment my dogs have received at the Dick Vet has been beyond words - the vets always empathise with their clients and go the extra mile to help. I'm delighted to lay this first brick in the new garden and hope this will encourage others to do the same, as a way of thanking the Dick Vet."
(Photos courtesy Norrie Russell, University of Edinburgh)
Bayer Animal Health has re-designed Drontal Cat and Drontal Cat XL tablets from a round shape to a smaller ellipsoid one, in order to make worming an easier process.
Bayer's Drontal brand manager Dan White said: "Market research conducted among 218 cat owners in August revealed that an ellipsoid, smaller tablet was preferred. In fact, 69% of non-Drontal Cat users indicated they would prefer to switch from their current worming product to an ellipsoid, smaller tablet. So we have re-designed the shape of the tablet across the Drontal Cat range.
"Drontal is the only wormer that kills every type of gastrointestinal worm commonly found in UK cats. So it was not surprising the research also showed Drontal to have the highest brand awareness, at 37%, of all cat worming products."
The new Drontal Cat Ellipsoid tablets are now available, and in new pack sizes of 2, 24 and 96. For large cats, Drontal Cat XL Ellipsoid has new pack sizes of 2, 8, and 48, and these packs will be available in early 2011.
For more information about the new Drontal Cat tablets, please contact your Bayer territory manager.
The draw, which is open to UK mainland veterinary practices, can be entered here until 31st January 2018.
Fiona Sturgess, Vetlab's Sales and Marketing Manager, said: “The CombiSpin is designed for centrifuging relatively small volumes of biological liquids. It’s also very quiet, making it ideally suited for veterinary practice laboratories.
“So whether you’re entering on your own behalf as a practice owner, or to win one for your boss, it’s a great prize to win, and your chances are a lot better than with the National Lottery!"
Everyone who enters the draw (apart from the winner, of course), will be given 20% off the price of a new CombiSpin for their practice, valid to the end of the year.
More information about the CombiSpin is available here: http://vetlabsupplies.co.uk/products/combispin-veterinary-centrifuge/
The outreach programme began earlier this month at the Devon County Show (pictured right), where the College used the opportunity to spread the word about its petsneedvets campaign, handing out over 1000 promotional bags in the process.
Next on the itinerary is the Royal Welsh Show near Builth Wells from the 23rd to 26th July. From there, the College will be heading to the BBC Countryfile Live event, held in the grounds of Blenheim Palace in Oxfordshire from the 2nd to 5th August.
Ian Holloway, Director of Communications at the RCVS, said: "Following the success and popularity of our stand at Countryfile Live over the past two years we decided that this year we would broaden our horizons and attend some of the UK’s most prestigious and well-attended regional events.
"We have our ever-popular careers materials available, and it was wonderful to see dozens of young people at the Devon County Show asking us about how they can become veterinary surgeons and veterinary nurses, as they always have the past two years at Countryfile. This is a really encouraging level of interest in the professions and we’re very happy to provide information to help them fulfil their aspirations.
"Attending more and different public events is a trend we are very keen on continuing with and we will be looking at other events to attend in different parts of the UK for next year."
For more information about upcoming events involving the RCVS visit www.rcvs.org.uk/events
Photo: Royal College of Veterinary Surgeons
The training facility is over 800m2 and houses 18 working stations, three lecture rooms, the latest training technology, a leisure area and library with outdoor space and parking.
Heber Alves, CEO of the Improve International Group said: “It has been a goal of ours for a long time to open a new, top-of-the-range training facility for veterinary professionals in Germany.
"We are delighted to see this dream come true and we are very excited to now have the opportunity to work more closely with vets and veterinary technicians and help them grow their skillsets.”
www.improveinternational.com.
For the study, urinalysis results from 2,712 UK feline urine samples submitted and analysed by Axiom and Finn over a period of 14 months2 were reviewed.
Urine samples had to have been obtained by cystocentesis and signalment information recorded by their submitting vet3.
These samples did not have to come from cats presenting with FLUTD signs and the researchers therefore say that consideration should be given to a different (potentially even more increased) prevalence in cats presenting with LUT signs.
Bacterial urinary tract infections in cats with FLUTD are estimated to be present in around 8 – 19% of cases4.
However, FLUTD is one of the most common reasons for the use of antimicrobial drugs in veterinary medicine and is therefore an important condition to consider to minimise antimicrobial use and development of antimicrobial resistance5.
The study found that 15.7% of the samples had a positive culture, with E. coli (43.7%), other Enterobacterales (26.4%) and Enterococcus spp (14.9%) being the most common isolates identified.
Antimicrobial susceptibilities and resistance were also tested.
Notably, Enterococcus species were frequently found to be resistant to multiple antibiotics, and several other isolates demonstrated resistance to frequently used antibiotics.
The data showed Enterococcus spp. were much less susceptible to trimethoprim and sulfamethoxazole (TMPS) than have been previously documented (with 94% of isolates resistant).
Additionally, other Enterobacterales had resistance against cephalosporins and penicillins.
The authors say that data surrounding cephalosporin resistance is particularly notable and problematic; recent data has indeed shown that the cephalosporin cefovecin is a commonly prescribed antibiotic3 for cats presenting with lower urinary tract disease.
The authors also say that data in this study adds to the existing evidence that the use of cephalosporins such as cefovecin may be ineffective in many cases (intrinsic resistance of Enterococcus spp) and therefore should be avoided unless cystocentesis and signalment results support their use.
The inappropriate use of antibiotics for bacterial cystitis could not only be ineffective to manage bacterial cystitis in cats but promote further antimicrobial resistance.
Clarisse D’Août, lead author of the research and Internal Medicine Specialist at Lumbry Park Veterinary Specialists, said: “Even though feline lower urinary tract disease is one of the most common reasons for vets to prescribe antibiotics, the prevalence of bacterial strains in the urine of cats with this condition, and their resistance to commonly used antibiotics, had not been widely studied in the UK to date.
"So we hope that this study can add to the current evidence to making well-justified and practical recommendations in practices about which antibiotics to choose and those to avoid.
"We see this ongoing susceptibility testing as clinically important to avoid the development of further resistant bacteria.”
References
The RSPCA is asking veterinary surgeons to take part in a new survey which aims to build a true picture of the scale of the problem of illegally imported puppies being brought into the UK.
Amongst other things, the survey asks what you consider to be the greatest concerns regarding the poor breeding, dealing and illegal import of puppies and what you think can be done to tackle these and the associated problems.
You can take part in the survey here: www.surveymonkey.com/s/QQNBVFV
James Yeates, Chief Veterinary Officer, said: "RSPCA intelligence suggests that there is a growing illegal trade in puppies from other EU countries and is causing serious health and welfare problems. In many cases puppies are dying or becoming seriously ill. Risk factors appear to include being taken from their mothers too early, not being vaccinated and having to endure long journeys in poor conditions.
"However, it's very difficult to get a full view on the scale of the problem as many cases never get reported to the RSPCA. Vets are likely to be the first port of call when a puppy bought by an unsuspecting buyer becomes sick and may be faced with many of these cases - if sadly not all.
"We're interested in hearing from vets to get their evidence from practice and to hear their ideas about how we can tackle the lucrative illegal trade in puppies."
For those not familiar with the term, moral injury is the damage to your conscience when you witness, perpetrate or fail to stop an event which conflicts with your moral beliefs. The study looking into this phenomenon in the veterinary profession is being conducted at King’s College London by Professor Neil Greenberg (pictured right), Dr Dominic Murphy and Dr Victoria Williamson, who will investigate the types of moral injuries veterinary professionals might encounter, their prevalence, the perceptions amongst professionals around how these moral injuries come about, and what support is needed when they occur.
The second project, titled 'Experiences of racism and its impacts on mental wellbeing in Black, Asian and Minority Ethnic (BAME) people working and studying in the UK veterinary profession' is being conducted by the Royal Veterinary College and British Veterinary Ethnicity & Diversity Society. As well as gathering information about experiences of racism and their impact, the project will also determine what individuals from the BAME veterinary community think could, and should, be done to tackle racism in the veterinary professions, and gather the evidence to help design appropriate interventions for those whose mental health and wellbeing is impacted by racism and discrimination.
Professor Susan Dawson, Chair of the Mind Matters Initiative, said: “Though it was a tough decision to choose the recipients of this year’s grants as all the applications were of a high standard, these two stood out because they are investigating two issues that we know are there, but which we don’t yet have the evidence-base for to really determine their prevalence, their impact and how we, as a profession, can tackle them more effectively.
“They also stood out for being solutions-focused in that the evidence will be used to find the best interventions and support mechanisms for those whose mental health has been impacted by racism and moral injury. We would like to congratulate the two research teams and look forward to working with them over the coming years.”
Have you suffered from moral injury or racism in the veterinary profession? Come and discuss here.
B&W operates an integrated practice based around a multi-disciplinary referral hospital in Breadstone, Gloucestershire, with additional clinics in Cardiff, Gloucestershire and Bristol. The group employs more than 30 veterinary surgeons, including seven diploma holders, and offers a full range of services, including what it says is the most comprehensive equine imaging service in the UK.
Ian Camm, Managing Director of B&W, will continue in the role of Equine Regional Director for the South West at CVS. He said: "We are excited about life within CVS and see many opportunities for our staff both within B&W and within the wider Equine Division at CVS. We look forward to working with the CVS team to realise the potential the partnership offers to members of our team and to further developing B&W as an equine veterinary centre of excellence."
Simon Innes, Chief Executive at CVS, said: "Our Equine Division has grown rapidly over the last 18 months because we offer an ambitious and exciting vision for the future of equine practice. B&W is one of the UK’s premier equine practices and we are delighted to welcome the team to CVS and look forward to working with them to help them build an even more successful future."
In an AI position statement released on their website, the company highlights the opportunities and risks associated with the use of AI to interpret diagnostic images.
In the joint statement, company owners Victoria Johnson and Julien Labruyère (pictured right), said: “We strongly welcome the introduction of appropriately developed, tested and implemented AI tools into our profession, to provide solutions to improve resourcing and benefit animal welfare.
“There is a limited pool of veterinary radiologists and an ever-increasing need for expert interpretation of radiographs and more advanced diagnostic imaging modalities.
"This presents a huge opportunity for the development of AI and related technologies to better address demand, save time and potentially improve clinical knowledge and outcomes.
"However, it is important to note that, unlike human radiology, there is no official framework for the regulation, governance and quality control of AI tools in veterinary radiology.
"This means that there should be a very strong onus on companies and individuals to adhere to the highest standards of medical tool development when creating AI solutions.”
“If AI is released into veterinary practice without appropriate oversight or governance there is a significant risk of misleading results, misdiagnosis, and negative impacts on patient welfare.
"This, in turn, may undermine trust in AI and create a culture of hesitancy to adopt new technologies at a time when innovation is much needed to improve access to advanced care.”
The company is advocating for a series of self-regulatory measures to be applied by companies developing AI in order to safeguard both animal welfare and the liability of the veterinary surgeons using these tools in clinical practice.
The full position statement and a list of recommendations can be here: https://www.vet-ct.com/gb/our-services/ai-veterinary-radiology/
Boehringer Ingelheim Vetmedica has launched Benefortin (benazepril hydrochloride), an ACE inhibitor licensed for the treatment of congestive heart failure (CHF) in dogs. It is also licensed for the treatment of chronic renal insufficiency (CRI) in cats.
Benefortin uses novel micro-cap technology to mask the taste of the bitter molecule. According to Boehringer, this ensures that Benefortin tastes good1, even if it is bitten, crunched or chewed. The company says taste tests demonstrated 100% palatability in dogs and 92% palatability in cats in home settings1.
Benefortin is available in 5mg and 20mg tablets for dogs and 2.5mg tablets for cats and dogs.
Jemima Scott, Boehringer Ingelheim brand manager said: "The addition of Benefortin to our cardiology portfolio now enables us to provide veterinary practices with two of the cornerstones of canine CHF treatment, and the palatability of Benefortin makes it an excellent choice for vets needing to prescribe an ACE inhibitor."
To support the launch of Benefortin, Boehringer is offering veterinary practices the opportunity to win one of three Bosch microwave ovens in a prize draw by answering three multiple choice questions on the ACE inhibitor.
For further information on Benefortin, contact your local Boehringer Ingelheim Vetmedica territory manager or telephone 01344 746959.
Tri-Solfen contains lidocaine and bupivacaine to deliver rapid onset and prolonged local anaesthesia, adrenalin to reduce blood loss and cetrimide to lower the risk of infection.
Dechra says the gel is effective in 30 seconds, making it a practical tool to improve animal welfare via cutaneous and epilesional use.
Tri-Solfen was originally developed and launched in Australia by Medical Ethics, a company that specialises in pain management treatments for humans and animals.
According to the company, more than 100 million animals have been treated with Tri-Solfen in Australia, New Zealand and Portugal, where it is licensed for disbudding, dehorning, castration and general wound treatments in cattle, sheep, pigs and horses.
www.dechra.co.uk
The webinar will be presented by Marge Chandler DVM, MS, MANZCVS, DACVIM (SAIM, Nutrition), MRCVS and Dr Michael Lappin DVM, PhD, DACVIM.
Marge is an independent consultant in small animal nutrition and internal medicine and Chair of the FEDIAF Scientific Advisory Committee, founding member of the European Veterinary Nutrition Educators Group, and Co-Chair of the WSAVA Global Nutrition Committee.
Michael is the Kenneth W. Smith Professor in Small Animal Clinical Veterinary Medicine and Director of the Center for Companion Animal Studies at Colorado State University. He is on the editorial board of Feline Medicine and Surgery and Compendium on Continuing Education for the Practicing Veterinarian and is the editor of the textbook, Feline Internal Medicine Secrets.
The webinar will discuss the value supplements can offer to pets who are already on complete diets, how supplements are regulated and the importance of quality control.
The session will also cover the challenges for vets in selecting supplements for their clinical practice, what factors can determine the choice of supplement, and how you can critically evaluate the evidence supporting a supplement.
Marge and Michael will also provide tips for communicating the benefits of supplements to clients.
Daniel Rodes Moltó of the Purina Institute said: “We are pleased to offer this interactive webinar on how to evaluate and select supplements using an evidence-based approach in a non-promotional setting.
"Webinar attendees are welcome to submit questions for our speakers in advance and to ask questions during the live event, which promises to be an enjoyable and lively session supporting the aim of improving the lives of pets.”
https://webapp.spotme.com/login/eventspace/CollaborativeCareMay2023
CVS has announced the acquisition of four further veterinary practices bringing the total number of practices it owns across the UK to 92 operating from 253 sites.
The latest practices to join CVS are: Crescent Veterinary Clinic Ltd, Melton Mowbray; Miller & Swann Veterinary Surgery, Elgin; West Mount Vets, Halifax and Anchorage Veterinary Hospital, Acle.
CVS now employs more than 2,300 staff at its veterinary practices and surgeries across the UK and in its related veterinary businesses, including an online pharmacy, two pet crematoriums and six veterinary laboratories.
The Blue Cross is offering a lifeline to even more needy pets across the UK following an extension to its successful veterinary grant scheme.
Relaunched as “The Blue Cross Veterinary Care Fund”, the charity has increased available funding and doubled the maximum grant it will pay towards veterinary costs of a particular treatment, operation or neutering procedure if the owner can't afford it.
The initiative was first launched in 2005 to help pet owners on low incomes who do not live near Blue Cross hospitals or clinics. So far the charity has awarded thousands of grants through 1,100 veterinary practices, 28% of all private vets in the UK. The demand from needy pets around the country prompted The Blue Cross to increase the maximum grant to £200 towards the veterinary treatment costs.
Pet owners must be on a means tested benefit or state pension with no other income to be eligible for support through the Veterinary Care Fund. Those on a very low income may also be eligible for the grant and should contact The Blue Cross for further advice.
The charity is also opening a new veterinary welfare clinic on 3 June 2008. The clinic, based at the animal adoption centre in Tiverton, will carry out basic procedures such as microchipping and vaccinations, and treat minor ailments. More serious or complicated cases will be referred to a local veterinary practice where treatment will be subsidised by The Blue Cross.
For more information about the Veterinary Care Fund or how clients can apply please contact The Blue Cross customer care team on 01993 825593 or email info@bluecross.org.uk
Liz, co-founder of WellVet, will present data from a survey conducted by SPVS and Veterinary Woman: ‘Menopause and the Effect on Veterinary Professionals and Teams’, which showed the impact of menopause on an important, experienced demographic, with up to 80% of women experiencing negative physical and mental effects, which are moderate to severe in 30% of women1.
Belinda, Post Doctoral Research Fellow at the University of Edinburgh will present on conclusions from her research on menopause at work.
Belinda will also share findings from the government-funded Supporting Healthy Ageing at Work (SHAW) Project, a 3-year investigation into hidden health factors affecting how workers over 50 engage with work.
Her presentation will include a synopsis of suggested workplace interventions to trial as a result of this research.
The session will discuss possible solutions to support improved retention and happier, healthier work for longer across the veterinary sector. It will present an opportunity for veterinary teams to be part of the phase 3 of the SHAW project and trial the evidence-based workplace interventions that have emerged from the phase 1 data.
Liz said: “We could be doing a lot more to support healthier, longer working lives for many women impacted.
“If you are unable to attend this session, please encourage representatives from across your organisations and businesses to attend.
"This could be the start of a hugely positive pan-profession move to improve working life for many.”
The session will take place on 18th November 2022 from 15:45 – 16:35 at London Vet Show in the Business Theatre. https://london.vetshow.com/conference-programme-2022/menopause-interventions-in-veterinary-practice
Webinarvet will be hosting a lead-in session to this on 15th October 2022 at 8pm. https://www.thewebinarvet.com/webinar/the-m-word-now-is-the-time-to-talk-about-it
Intervet/Schering-Plough Animal Health has announced the launch of PORCILIS AR-T DF, an inactivated vaccine against progressive atrophic rhinitis in piglets with a new adjuvant which the company says is associated with fewer injection site reactions.
PORCILIS AR-T DF uses DILUVAC FORTE (DF), an aqueous vitamin E-based adjuvant and will replace PORCILIS AR-T, a similar vaccine containing an oil-based adjuvant. The newly formulated vaccine is approved to reduce the clinical signs of progressive atrophic rhinitis in their offspring. Progressive atrophic rhinitis is caused by a toxin from the bacteria Pasteurella multocida affecting bone-forming cells in the snout of the young piglet.
Marc Dickie, Senior Director, Global Swine Business Unit at Intervet/Schering-Plough Animal Health said: "The innovative PORCILIS AR-T DF vaccine combines the proven efficacy of the current PORCILIS AR-T with an improved safety profile and convenience for the veterinarian that is offered by the aqueous DILUVAC FORTE adjuvant. The new vaccine also demonstrates the commitment of our company to continuously improve our vaccines, thereby offering value-added benefits to our customers."
Companion Care has opened its 80th surgery, within the Ilford Pets at Home store.
Companion Care Vets managing director, Jane Balmain said: "The opening of our 80th surgery proves the success of our joint venture partner business model. At present the majority of our surgeries are located inside Pets at Home stores but we also have four very successful standalone surgeries. Our standalone surgery network is now being developed to create further exciting opportunities for future growth, with our first new standalone surgery opening in Scotland this December."
Joint venture partner and veterinary surgeon at Companion Care Vets Ilford Alberto Arciniega said: "Alongside the fantastic team we have on board, my partners Nick and Claire and I are extremely proud to be opening our second surgery here in Ilford. Having been partners at the Romford surgery since July 2009 we have seen the company grow consistently and successfully. We feel honoured to be opening the groups' 80th surgery and look forward to the challenge of managing both practices and to delivering outstanding veterinary care."
With 102 Joint Veterinary Partners, 83 of whom are veterinary surgeons, 12 veterinary nurses, 6 practice managers and 1 receptionist and a further 789 staff employed by the group Companion Care Vets is one of the largest veterinary employers in the UK. Dividend payments to joint venture partners in the 2010/2011 period totalled £2.181 million and the group says it plans to open a further 10 surgeries across the UK before the end of year.
Tramadol has become a controlled drug and has been added to Schedule 3 of the Misuse of Drugs Regulations 2001
The change to the regulations, which was made by the Home Office means that the drug is now subject to special requirements when writing prescriptions.
The RCVS says practitioners should also note that:
Although tramadol is exempt from Safe Custody Regulations, the RCVS advises that all Schedule 3 controlled drugs are locked away.
The Home Office has also reclassified ketamine as a Class B controlled drug. However, it remains under Schedule 4 (Part 1) of the 2001 Regulations meaning that the legal requirements for supply, storage and record keeping remain the same.
The RCVS therefore continues to advise that practice premises should:
Further details about the specific requirements for controlled drugs can be found in the Veterinary Medicines Directorate’s Guidance Note No 20 – Controlled Drugs.
Practice premises can also contact the RCVS Professional Conduct Department for further guidance on 020 7202 0789 or profcon@rcvs.org.uk.
The 2,200sqm building – equivalent to half a hockey pitch or four netball courts – will include a range of facilities across two floors. It will have two new lecture theatres, a number of IT-rich teaching and learning spaces, general teaching rooms and various environments for teaching clinical skills.
The University’s Vice-Chancellor, Dr David Llewellyn, said: "Our plans for the Veterinary School are proceeding well, with our first student intake to the new veterinary medicine course due in 2020.
"The building on the Harper Adams site will provide a great range of teaching facilities for our students, to complement the wide range of animal facilities we already have on campus. We are excited to see the progress that is being made with the Harper & Keele Veterinary School, which is generating considerable interest within the veterinary profession, and we look forward to seeing the new building take shape in the coming months."
Picture shows: Vice Chancellor Dr David Llewellyn, McPhillips’ Marketing Manager Mark Kiddie, Site Manager Ed Bickford, McPhillips’ Managing Director Paul Inions, Head of Estates and Facilities at Harper Adams University, Jonathan Cain,